Stromal interaction molecules as important therapeutic targets indiseases with dysregulated calcium flux. Brooks Department of Chemistry, University of South Florida, Tampa, FL, USA 2014 Oct;1843(10):2307-2314.
Structural basis for Ca2+-induced activation of human PAD4. Nat Struct Mol Biol 2004;11(8):777-783.
Calcium homeostasis: hypercalcemia and hypocalcemia. 2nd ed. London: Martin Dunit 1990;1-16.
Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis. Prostate 1997;30(3):183-187.
Bone turnover mediates preferential localization of prostate cancer in the skeleton. Endocrinology 2005;146(4):1727-1736.
Hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/paracrine and intracrine pathways. Regul Pept 2002;105(2):109-120.
Immunohistochemical localization of parathyroid hormone-related protein in prostatic intraepithelial neoplasia. Hum Pathol 1995;26(7):797-801.
Enhanced expression of parathyroid hormone-related protein in prostate cancer as compared with benign prostatic hyperplasia. Hum Pathol 1996;27(12):1319-1323.
Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormonerelated peptide secretion in human breast cancer cell lines. Endocrinology 2000;141(12):4357-4364.
Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation. Bone 2004;35(3):664-672.
The calciumsensing receptor regulates plasma membrane calcium adenosine triphosphatase isoform 2 activity in mammary epithelial cells: a mechanism for calcium-regulated calcium transport into milk. Endocrinology 2007;148(12):5943-5954.
Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Res 2007;67(19):9542-9548.
Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells. J Biol Chem 2008;283(36):24435-24447.
G-proteincoupled, extracellular Ca(2)-sensing receptor: a versatile regulator of diverse cellular functions. Vitam Horm 1999;55:1-71.
Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 2001;280(2):F291-F302.
Mitogen-activated protein kinase cascade in human normal and tumoral parathyroid cells. J Clin Endocrinol Metab 2002;87(5):2201-2205.
PTHrP stimulated by the calcium-sensing receptor requires MAP kinase activation. Am J Physiol Endocrinol Metab 2003;284(2):E435-E442.
Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia. Clin Endocrinol (Oxf) 2000;52(3):339-348.
Vitamin D and the epidemiology of prostate cancer. Semin Dial 2005;18:276-289.
Regulation of intracellular calcium in breast cancer cells. Endocrine 1998:321-327.
Vitamin D and intracellular calcium. Subcell Biochem 1998;30:271-297.
Calcium as a mediator of 1,25-dihydroxyvitamin D3-induced apoptosis. J Steroid Biochem Mol Biol 2004;89-90(1-5):419-425.
Calcium signaling in cancer and vitamin D. Steroid Biochemistry and Molecular Biology 2005;97(1-2):145-151.
Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 1991 Nov 15;254(5034):1022-1024.
Down regulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast- like cell differentiation. J Clin Investig 1995;95(1):167-171.
Expression of calcium-sensing receptor and characterization of intracellular signaling in human pituitary adenomas. J Clin Endocrinol Metab 1999;84(8):2848-2853.
Calcium-sensing receptor expression and regulation by extracellular calcium in the AtT-20 pituitary cell line. Mol Endocrinol ogy 1996;10(5):555-565.
Effects of divalent cations and of a calcimimetic on adre-nocorticotropic hormone release in pituitary tumor cells. Biochem Biophys Res Commun 1997;238(3):866-873.